Search - Archive ouverte HAL Access content directly

Filter your results

68 Results
Structure: Internal structure identifier : 59772

Differential Effect Triggered by a Heparan Mimetic of the RGTA Family Preventing Oral Mucositis Without Tumor Protection

Monica Mangoni , Xiaoli Yue , Christophe Morin , Dominique Violot , Valerie Frascogna et al.
International Journal of Radiation Oncology, Biology, Physics, 2009, 74 (4), pp.1242 - 1250. ⟨10.1016/j.ijrobp.2009.03.006⟩
Journal articles hal-01756691v1
Image document

The ENCCA‑WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report

Leo Kager , Jeremy Whelan , Uta Dirksen , Bass Hassan , Jakob Anninga et al.
Sarcoma Networking Meeting, 2015, vienne, Austria. pp.eCollection 2016, ⟨10.1186/s13569-016-0043-5⟩
Conference papers inserm-01701158v1
Image document

Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments

Séverine Coquerelle , Meryl Darlington , Morgane Michel , Manon Durand , Isabelle Borget et al.
Value in Health, 2020, 23 (7), pp. 898-906. ⟨10.1016/j.jval.2020.03.005⟩
Journal articles halshs-02983051v1

JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome

R. M'Kacher , L. Andreoletti , S. Flamant , F. Milliat , T. Girinsky et al.
Annals of Oncology, 2009, 21 (4), pp.826-832. ⟨10.1093/annonc/mdp375⟩
Journal articles hal-02993481v1
Image document

Prediction of Drug Approval After Phase I Clinical Trials in Oncology -RESOLVED2

Guillaume Beinse , Virgile Tellier , Valentin Charvet , Eric Deutsch , Isabelle Borget et al.
JCO Clinical Cancer Informatics, 2019, 3, pp.1-10. ⟨10.1200/CCI.19.00023⟩
Journal articles hal-02894327v1

Escherichia coli –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

Anne-Gaëlle Goubet , Leonardo Lordello , Carolina Alves Costa Silva , Isabelle Peguillet , Marianne Gazzano et al.
Cancer Discovery, 2022, 12 (10), pp.2280-2307. ⟨10.1158/2159-8290.CD-22-0201⟩
Journal articles hal-03951702v1

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

L. Marthey , C. Mateus , C. Mussini , M. Nachury , S. Nancey et al.
Journal of Crohn's and Colitis, 2016, 10 (4), pp.395-401. ⟨10.1093/ecco-jcc/jjv227⟩
Journal articles hal-01659102v1

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1

Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France

A. Auperin , R. Obongo , F.R. Ferrand , N. Saroul , F. Janot et al.
European Journal of Cancer, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
Journal articles hal-02548630v1

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Nathalie Chaput , Patricia Lepage , Clelia Coutzac , E Soularue , Karine Le Roux et al.
Annals of Oncology, 2017, ⟨10.1093/annonc/mdx108⟩
Journal articles hal-01604339v1

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

Yann Neuzillet , Xavier Paoletti , Slah Ouerhani , Pierre Mongiat-Artus , Hany Soliman et al.
PLoS ONE, 2012, 7 (12), ⟨10.1371/journal.pone.0048993⟩
Journal articles hal-01358546v1
Image document

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Jane Merlevede , Nathalie Droin , Tingting Qin , Kristen Meldi , Kenichi Yoshida et al.
Nature Communications, 2016, 7 (1), ⟨10.1038/ncomms10767⟩
Journal articles hal-03130526v1
Image document

Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France

Cécile Charles , Aurélie Bardet , Alicia Larive , Philip Gorwood , Nicolas Ramoz et al.
JAMA Network Open, 2022, 5 (4), pp.e225118. ⟨10.1001/jamanetworkopen.2022.5118⟩
Journal articles inserm-03650391v1

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care

Antonio Di Meglio , Julie Havas , Davide Soldato , Daniele Presti , Elise Martin et al.
Journal of Clinical Oncology, 2022, 40 (10), pp.1111--1123. ⟨10.1200/JCO.21.01252⟩
Journal articles hal-03855945v1

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Dimitri Carene , Alicia Tran-Dien , Jérôme Lemonnier , Florence Dalenc , Christelle Levy et al.
Breast Cancer Research and Treatment, 2020, 179 (2), pp.387-401. ⟨10.1007/s10549-019-05462-y⟩
Journal articles hal-03769556v1

Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis

Nicolas Penel , Sylvie Bonvalot , André-Michel Bimbai , Alexandra Meurgey , François Le Loarer et al.
Clinical Cancer Research, 2022, 28 (18), pp.4105-4111. ⟨10.1158/1078-0432.CCR-21-4235⟩
Journal articles hal-03925659v1

A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency.

A. S. Lebre , M. Rio , L. Faivre d'Arcier , D. Vernerey , P. Landrieu et al.
Journal of Medical Genetics, 2011, 48 (1), pp.16-23. ⟨10.1136/jmg.2010.079624⟩
Journal articles istex hal-00795725v1
Image document

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag , Serge Koscielny , Jacques Bosq , Thibaut Leguay , Olivier Casasnovas et al.
The Lancet, 2016, 387 (10036), pp.2402 - 2411. ⟨10.1016/S0140-6736(15)01317-3⟩
Journal articles inserm-01419476v1
Image document

A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events

Jia Li , Marie-Anne Poursat , Damien Drubay , Arnaud Motz , Zohra Saci et al.
PLoS Computational Biology, 2015, 11 (11), pp.e1004583. ⟨10.1371/journal.pcbi.1004583⟩
Journal articles hal-01274705v1

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort

M. Kandel , C. Allayous , S. Dalle , L. Mortier , S. Dalac et al.
European Journal of Cancer, 2018, 105, pp.33--40. ⟨10.1016/j.ejca.2018.09.026⟩
Journal articles hal-02313525v1

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

N. Lassau , B. Coiffier , M. Kind , V. Vilgrain , J. Lacroix et al.
Annals of Oncology, 2016, 27 (10), pp.1922 - 1928. ⟨10.1093/annonc/mdw280⟩
Journal articles hal-01830001v1
Image document

Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma

Fanélie Jouenne , Isaure Chauvot de Beauchêne , Emeline Bollaert , Marie-Francoise Avril , Olivier Caron et al.
Journal of Medical Genetics, 2017, 54 (9), pp.607-612. ⟨10.1136/jmedgenet-2016-104402⟩
Journal articles hal-01580787v1

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting―IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms

Michèle Beau-Faller , Hélène Blons , Caroline Domerg , Dorota Gajda , Nicolas Richard et al.
Journal of Molecular Diagnostics, 2014, 16 (1), pp.45--55. ⟨10.1016/j.jmoldx.2013.07.009⟩
Journal articles hal-01064291v1
Image document

Efficacy of Vaccination against HPV infections to prevent cervical cancer in France

Laureen Ribassin-Majed , Catherine Hill , Rachid Lounes
Public Health, 2015, 129 (1), pp.78-81
Journal articles hal-01058771v1
Image document

Screening for SARS-CoV-2 by RT-PCR: Saliva or nasopharyngeal swab? Rapid review and meta-analysis

Nusaïbah Ibrahimi , Agnès Delaunay-Moisan , Catherine Hill , Gwénaël Le Teuff , Jean-François Rupprecht et al.
PLoS ONE, 2021, 16 (6), pp.e0253007. ⟨10.1371/journal.pone.0253007⟩
Journal articles hal-03258703v1
Image document

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Gladys Ferrere , Maryam Tidjani Alou , Peng Liu , Anne-Gaëlle Goubet , Marine Fidelle et al.
JCI Insight, 2021, 6 (2), ⟨10.1172/jci⟩
Journal articles hal-03169306v1

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier , Anne Floquet , Christine Chevreau , Nicolas Penel , Cécile Guillemet et al.
Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩
Journal articles hal-03623745v1
Image document

Imperfect biomarkers for adjuvant chemotherapy in early stage breast cancer with good prognosis

Catherine Bourgain , Lionel Pourtau , Chafika Mazouni , Catherine Bungener , Julia Bonastre et al.
Social science & medicine, 2020, 246, pp.112735. ⟨10.1016/j.socscimed.2019.112735⟩
Journal articles halshs-02481652v1


Lionel Perrier , S. Baffert , A. Bertaux , J. Bonastre , N. Costa et al.
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66, pp.S63 - S64. ⟨10.1016/j.respe.2018.02.004⟩
Journal articles halshs-01819359v1
Image document

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez-Brouchet , Claire Illac , Julia Gilhodes , Corinne Bouvier , Sébastien Aubert et al.
OncoImmunology, 2017, 6 (9), pp.e1331193 (eCollection 2017). ⟨10.1080/2162402X.2017.1331193⟩
Journal articles inserm-01701844v1